News and Trends 17 Sep 2019European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis at a conference in Stockholm. … September 17, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Mar 2019Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing… March 12, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 26 Mar 2018Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II GeNeuro has released Phase IIb data showing that its antibody can reduce brain damage in patients with multiple sclerosis by… March 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2018This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease The FDA has awarded Orphan Drug Designation to GeNeuro's antibody for the treatment of a rare autoimmune disease following promising… February 26, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 1 Nov 2017Swiss Biotech & French Pharma Reverse Damage in Multiple Sclerosis A candidate multiple sclerosis treatment from GeNeuro and its partner Servier showed some remyelination in a post hoc analysis of Phase IIb… November 1, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 May 2017In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight Geneva is the largest city in French-speaking Switzerland, a financial powerhouse, home to the United Nations and known as the… May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
In Depth 25 Apr 2017How Biotech is Mastering Multiple Sclerosis: A Review With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis. Roche may be the first,… April 25, 2017 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2016Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment GeNeuro is developing a unique treatment for multiple sclerosis. We interviewed Miguel Payro, the company's CFO, who explained its advantageous position against big… September 30, 2016 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Apr 2016First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis! We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase… April 16, 2016 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2014Will there be a New Merck-Serono? GeNeuro SA has signed a unique partnership with Servier. The French pharmaceutical giant have bought an option for €38M on… December 15, 2014 - 2 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email